|
Post by jurystillout on Mar 3, 2015 17:15:24 GMT -5
I said my good bye's over a month ago however when it came down to parting with all of my shares I just couldn't do it, I did dump 75% of my holdings of this stock. My rational for holding on to a portion is due to the science and the belief in the product, the reason for selling was based on the shamefully stupid management at this company. I've never shorted a stock in my life and you can call me a basher if you like however for just one moment consider what I'm saying in a truly objective position. Everything is riding on how well Sny promotes and sells Affrezza. MNKD doesn't have any commitment from SNY to deliver or even try to market this product. MNKD borrowed money from SNY and everything in the company is collateral. MNKD signed a commitment to purchase a tremendous amount of insulin that they can't pay for unless SNY sells alot of Affrezza (Novel idea, a commitment). Inability to to purchase the insulin puts MNKD in default, MNKD will have to look for sources of capital (loan). Who in their right mind would loan them the kind of money they need? MNKD can't pay SNY, SNY becomes the new owner of affrezza and everything MNKD. Shareholder are left holding -0- nothing. If you think this scenario is far fetched it only takes one thing to put this whole chain of events into motion and from everything I've seen from SNY it's already begun. I'm completely dumbfounded that MNKD management would put this company at so much risk, they are completely incompetent business people. To sign a contract with SNY and not have a commitment, borrow money from them, use the company as collateral and give them complete control of whether or not it can be paid back, and then commit to purchase 100s of millions of dollars of insulin? What in the hell is wrong with them? The science, the product, the benefit of Affrezza are all outstanding, the management of this company is appalling! My last 10K shares are gone tomorrow. Good luck to all of you, I really do hope you do well. For me I'll get out with a little profit and move on.
|
|
|
Post by savzak on Mar 3, 2015 17:19:10 GMT -5
MNKD doesn't have any commitment from SNY to deliver or even try to market this product. What is your basis for this statement?
|
|
|
Post by jurystillout on Mar 3, 2015 17:24:02 GMT -5
The basis are the facts, Go to the 10-K and read the risk section, it spells it much better than I.
|
|
|
Post by cubonwallstreet on Mar 3, 2015 17:28:34 GMT -5
Well, you convinced me. Selling all my shares tomorrow.
|
|
|
Post by itrade on Mar 3, 2015 17:29:53 GMT -5
From your previous posts, you claim you have been holding this stock for 3 years, but can't hold after Afrezza has been launched??? Well, see ya later. Your remaining 10k shares will go to someone who understands what this stock has to offer.
|
|
|
Post by savzak on Mar 3, 2015 17:32:41 GMT -5
The basis are the facts, Go to the 10-K and read the risk section, it spells it much better than I. I read it. I found no provision that said " Sonofi has no legal obligation to deliver or even try to market Afrezza", nor any language to that effect. Perhaps I'm reading the wrong section. It is a very long document. Would you please quote the language from the 10-K you are referring to that spells this out so well? Thanks.
|
|
|
Post by ezrasfund on Mar 3, 2015 17:33:48 GMT -5
MNKD doesn't have any commitment from SNY to deliver or even try to market this product. What is your basis for this statement? I am betting Al Mann still thinks this will be the best selling drug of all time. Maybe he is right. Early adopters might agree. If Sanofi can get 2/3 of anything like that why would they put it on a shelf?
|
|
|
Post by mechstan on Mar 3, 2015 17:35:34 GMT -5
I said my good bye's over a month ago however when it came down to parting with all of my shares I just couldn't do it, I did dump 75% of my holdings of this stock. My rational for holding on to a portion is due to the science and the belief in the product, the reason for selling was based on the shamefully stupid management at this company. I've never shorted a stock in my life and you can call me a basher if you like however for just one moment consider what I'm saying in a truly objective position. Everything is riding on how well Sny promotes and sells Affrezza. MNKD doesn't have any commitment from SNY to deliver or even try to market this product. MNKD borrowed money from SNY and everything in the company is collateral. MNKD signed a commitment to purchase a tremendous amount of insulin that they can't pay for unless SNY sells alot of Affrezza (Novel idea, a commitment). Inability to to purchase the insulin puts MNKD in default, MNKD will have to look for sources of capital (loan). Who in their right mind would loan them the kind of money they need? MNKD can't pay SNY, SNY becomes the new owner of affrezza and everything MNKD. Shareholder are left holding -0- nothing. If you think this scenario is far fetched it only takes one thing to put this whole chain of events into motion and from everything I've seen from SNY it's already begun. I'm completely dumbfounded that MNKD management would put this company at so much risk, they are completely incompetent business people. To sign a contract with SNY and not have a commitment, borrow money from them, use the company as collateral and give them complete control of whether or not it can be paid back, and then commit to purchase 100s of millions of dollars of insulin? What in the hell is wrong with them? The science, the product, the benefit of Affrezza are all outstanding, the management of this company is appalling! My last 10K shares are gone tomorrow. Good luck to all of you, I really do hope you do well. For me I'll get out with a little profit and move on. Ok genius. I guess Al Mann doesn't know what he's doing. After 15+ companies he created and sold some for billions of dollars; after putting almost 1 billion dollars of his own money into MNKD; after 10+ years working for MNKD; after putting 80+ hours a week working for MNKD, I guess he still doesn't know what he's doing. After doing all this, I guess Al Mann and his team are stupid people. I guess only you know how MNKD should be managed. But even if that's true, most people bet their money with successful people such as Al Mann. It doesn't matter what you say. If you don't like MNKD management, sell and move on. You won't change people's mind, especially not mine. You're convinced that MNKD is no good and sold. Good for you. There are others who are convinced MNKD will be successful in the end and they're holding like me.
|
|
|
Post by dreamboatcruise on Mar 3, 2015 17:36:02 GMT -5
MNKD has not YET borrowed any money from Sanofi. Your rant would seem to imply they have.
|
|
|
Post by liane on Mar 3, 2015 17:36:45 GMT -5
All I see is typical boilerplate.
|
|
|
Post by ezrasfund on Mar 3, 2015 18:01:33 GMT -5
This thread shows just how vicious some folks can be on a bad day. LOL
|
|
|
Post by ashiwi on Mar 3, 2015 18:26:23 GMT -5
I would call $200 million in payments from SNY to MNKD so far and training 1200 SNY reps about Afrezza a commitment.
As the old expression says there are only 2 things in life that are guaranteed. Taxes and Death. And MNKD has $2 billion expenses on the books so they won't be paying taxes for a while.
|
|
|
Post by Chris-C on Mar 3, 2015 19:10:27 GMT -5
I said my good bye's over a month ago however when it came down to parting with all of my shares I just couldn't do it, I did dump 75% of my holdings of this stock. My rational for holding on to a portion is due to the science and the belief in the product, the reason for selling was based on the shamefully stupid management at this company. I've never shorted a stock in my life and you can call me a basher if you like however for just one moment consider what I'm saying in a truly objective position. Everything is riding on how well Sny promotes and sells Affrezza. MNKD doesn't have any commitment from SNY to deliver or even try to market this product. MNKD borrowed money from SNY and everything in the company is collateral. MNKD signed a commitment to purchase a tremendous amount of insulin that they can't pay for unless SNY sells alot of Affrezza (Novel idea, a commitment). Inability to to purchase the insulin puts MNKD in default, MNKD will have to look for sources of capital (loan). Who in their right mind would loan them the kind of money they need? MNKD can't pay SNY, SNY becomes the new owner of affrezza and everything MNKD. Shareholder are left holding -0- nothing. If you think this scenario is far fetched it only takes one thing to put this whole chain of events into motion and from everything I've seen from SNY it's already begun. I'm completely dumbfounded that MNKD management would put this company at so much risk, they are completely incompetent business people. To sign a contract with SNY and not have a commitment, borrow money from them, use the company as collateral and give them complete control of whether or not it can be paid back, and then commit to purchase 100s of millions of dollars of insulin? What in the hell is wrong with them? The science, the product, the benefit of Affrezza are all outstanding, the management of this company is appalling! My last 10K shares are gone tomorrow. Good luck to all of you, I really do hope you do well. For me I'll get out with a little profit and move on. Jurystillout Well, apparently the jury delivered a verdict as far as you're concerned, and you are certainly entitled to your own opinion. Adios, and feel free to check back in a year and see how the stock is doing. I'll be holding my shares, because not one material change has occurred with the company or the partners since the quarterly report. We did get a couple of negative opinions from mouths whose credibility is suspect because of documented duplicity in the past. But, as always when you are weighing opinions, consider the sources. I was curious about the "The Medical Letter" newsletter that was cited as an authoritative source for concern, so I did some sleuthing. The company somehow got classified as a 501c3 in 2002 (that means it's a non-profit scientific, charitable and educational organization providing a service to the public). But the company doesn't act or look like a non-profit. It sells subscriptions to its newsletter ($5M per year, actually) to clinics, physicians, other providers and medical libraries, and it compensates its board chair handsomely ($over $420K annually, as well as, oddly, its directors). I work in non-profits, so I find it strange that any tax exempt 501c3 would compensate members of its board and pay its CFO nearly $300K. But, putting that aside, their newsletter editor in chief is a PharmD hospital pharmacist who specialized (when she used to practice at Sloan Kettering) in acute infections. Dr. Pflomm appears not to have any scientific or academic experience, so maybe the conclusions of the Medical letter are taken verbatim from what the FDA publishes. This means, essentially, that the public service the newsletter provides is to summarize published information for medical professionals in a convenient format. It doesn't do original analysis on its own, it just regurgitates what other people write. So, this is the authoritative source that was used as a basis for one of today's hit pieces. Apparently, analysts don't expect investors to examine the bases underlying their arguments. The bottom line is this. Today's haircut was brought to you by people who had an agenda but no substantive reasons for changing their public views on the company. I think there is more excrement here if we dig hard enough, but I'm satisfied that the conclusions made by the long investors on this board are sound. Chris C
|
|
|
Post by print185 on Mar 3, 2015 19:12:00 GMT -5
and cubonwallstreet, the sky is falling so sell everything and move to the moon
are you for real?
|
|
|
Post by cubonwallstreet on Mar 3, 2015 19:16:07 GMT -5
I was being sarcastic, of course.
|
|